Human Podoplanin Biotinylated Antibody
Human Podoplanin Biotinylated Antibody Summary
Accession # Q86YL7
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Podoplanin, also known as glycoprotein 36 (gp36), PA2.26 antigen, T1-alpha (T1A), and aggrus, is a 36 kDa type I transmembrane sialoglycoprotein and member of the Podoplanin family (1‑2). Podoplanin has three potential splice variants, the longest of which is represented by a 238 amino acid (aa) precursor (NP_006465). It contains an undefined signal sequence, a 22 aa transmembrane segment (aa 207‑228) and a short cytoplasmic tail (aa 229‑238). The ECD contains abundant Ser/Thr residues that could serve as potential O‑linked glycosolation sites. The cytoplasmic tail contains putative sites for protein kinase C phosphorylation (2‑3). There are two potential alternate start sites at Met77 (Swiss Prot #: Q86YL7) and Met119 (EAW51692) that generate short forms. The 162 aa short form Podoplanin precursor shares 47% aa identity with mouse Podoplanin. Podoplanin is expressed on glomerular epithelial cells (podocytes), type I lung alveolar cells, lymphatic endothelial cells (4‑5), and numerous tumors, including colorectal tumors (3), squamous cell carcinomas (4, 6), testicular seminoma (7), and brain tumors (8‑10). One study shows high expression of Podoplanin mRNA in placenta, lung, skeletal muscle, and heart, and weaker levels in brain, kidney, and liver (1). Podoplanin is the ligand for C-type lectin-like receptor 2 (CLEC-2) (2). Their association is dependent on sialic acid on O-glycans of Podoplanin (2). Through its association with CLEC-2, Podoplanin induces platelet aggregation and tumor metastasis (2). Podoplanin is also necessary for lymphatic vessel formation, normal lung cell proliferation and alveolus formation at birth (2).
- Zimmer, G. et al. (1999) Biochem. J. 341:277.
- Katsue-Inoue, K. et al. (2007) J. Biol. Chem. 282:25993.
- Kato, Y. et al. (2003) J. Biol. Chem. 278:51599.
- Schacht, V. et al. (2005) Am. J. Pathol. 166:913.
- Breiteneder-Geleff, S. et al. (1997) Am. J. Pathol. 151:1141.
- Kato, Y. et al. (2005) Tumour Biol. 26:195.
- Kato, Y. et al. (2004) Oncogene 23:8552.
- Mishima, K. et al. (2006) Acta Neuropathol. 111:563.
- Mishima, K. et al. (2006) Acta Neuropathol. 111:483.
- Kato, Y. et al. (2006) Biochem. Biophys. Res. Commun. 349:1301.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Supplemental Cell Selection Products
Supplemental ELISA Products
Reviews for Human Podoplanin Biotinylated Antibody
There are currently no reviews for this product. Be the first to review Human Podoplanin Biotinylated Antibody and earn rewards!
Have you used Human Podoplanin Biotinylated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image